Presentation and Prognosis of Cryptococcosis Requiring Intensive Care Unit Admission in France: The CRYPTO-ICU Study
Clinical Infectious Diseases · 2026
DOI: 10.1093/cid/ciag091 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Simon Herbel und 37 weiteren Autor:innen. Beteiligte Einrichtung: Service de Médecine Intensive Réanimation, Département médico-universitaire ESPRIT, Hôpital Louis Mourier, Université Paris Cité, Assistance Publique…. Hauptthemen laut MEDLINE: Cryptococcosis, Intensive Care Units. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Alexion, Baxter, Gilead.
Themen: Intensivpflege
Abstract (Originalsprache)
Background
Cryptococcus causes life-threatening opportunistic infections in immunocompromised hosts. Data on the most severe cases requiring intensive care unit (ICU) admission remain limited.
Methods
We conducted a retrospective, multicenter study of patients admitted to 30 French ICUs for severe cryptococcosis between 2000 and 2022.
Results
Among 151 patients included, 56.9% were patients with human immunodeficiency virus (HIV). Cases in patients without HIV became increasingly prevalent over time (51.3% in 2012–2022 vs 32.4% before 2012); 82.5% were receiving immunosuppressive therapy. Central nervous system infection was predominant (91.1%), followed by lung infection (39.7%). Fungemia occurred in 59.8% patients, and 75.2% had disseminated infection. Neurological failure was the leading organ impairment at admission (75.5%) followed by respiratory failure (47.7%), acute kidney injury (41.7%), and shock (24.5%). The median Sequential Organ Failure Assessment (SOFA) score was 4 (interquartile range, 2–7). Invasive mechanical ventilation, vasopressors, and renal replacement therapy were required in 54.9%, 34.4%, and 18.5% of patients, respectively. At day 90, 94% of patients requiring mechanical ventilation and vasopressors were deceased, compared to 38.7% with invasive ventilation alone and 17.2% without any organ support (P < .001). Overall, 90-day mortality reached 49.6%. SOFA score (adjusted hazard ratio [aHR], 1.04 [95% confidence interval [CI], 1.02–1.06]), admission between 2000 and 2012 (aHR, 2.30 [95% CI, 1.36–3.89]), disseminated infection (aHR, 2.32 [95% CI, 1.15–4.67]), and initiation of antifungal therapy before ICU admission (aHR, 0.38 [95% CI, .22–.63]) were independently associated with 90-day mortality, whereas HIV serostatus was not (aHR, 0.93 [95% CI, .47–1.84]).
Conclusions
Severe cryptococcosis requiring ICU admission affects an increasing number of patients without HIV and is associated with high, though declining, mortality. Early diagnosis and treatment are mandatory to improve prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Service de Médecine Intensive Réanimation, Département médico-universitaire ESPRIT, Hôpital Louis Mourier, Université Paris Cité, Assistance Publique-Hôpitaux de Paris, Colombes, France.
- Service de Maladies infectieuses et tropicales, Hôpital Necker-Enfants Malades, Université Paris Cité, Assistance Publique-Hôpitaux de Paris, Paris, France.
- Service de Médecine Intensive Réanimation, Hôpital Saint-Antoine, Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Paris, France.
- Université Paris Cité, Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Médecine Intensive et Réanimation Infectieuse, Département médico-universitaire INVICTUS, Hôpital Bichat-Claude Ber…
- Service d'Otolaryngologie, Hôpital Pitié-Salpêtrière, Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Paris, France.
- Université Paris Cité, Inserm, U970, Centre de Recherche Cardiovasculaire de Paris, Epidémiologie intégrative des maladies cardiovasculaires, Paris, France.
ORCID-Profile: Simon Herbel, Olivier Paccoud, Étienne de Montmollin, Baptiste Grenier, Muriel Picard, Clara Vigneron, Juliette Guitard, Jérémie Joffre, Thomas Frapard, Valentin Coirier, Adrien Joseph, Julien Schmidt, Laurent Argaud, Maxens Decavèle, Mathieu Bellal, Vincent Das, Jean-Pierre Quenot, Fabrice Uhel, Damien Contou, Nahema Issa, Djamel Mokart, Naïke Bigé
Förderung
- Alexion
- Baxter
- Gilead
- Pfizer
- SOS Oxygène
- bioMérieux
- Oxyvie
Zitieren
APA
Herbel, S., Paccoud, O., de Montmollin, É., Grenier, B., Picard, M., Vigneron, C., Osman, D., Le Gall, A., Guitard, J., Joffre, J., Frapard, T., Coirier, V., Joseph, A., Schmidt, J., Argaud, L., Decavèle, M., Lacave, G., Voirot, G., Bellal, M., …, & GRRR-OH (Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologie) (2026). Presentation and Prognosis of Cryptococcosis Requiring Intensive Care Unit Admission in France: The CRYPTO-ICU Study. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag091
Vancouver
Herbel S, Paccoud O, de Montmollin É, Grenier B, Picard M, Vigneron C, et al. Presentation and Prognosis of Cryptococcosis Requiring Intensive Care Unit Admission in France: The CRYPTO-ICU Study. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag091
BibTeX
@article{Herbel2026,
author = {Herbel, Simon and Paccoud, Olivier and de Montmollin, Étienne and Grenier, Baptiste and Picard, Muriel and Vigneron, Clara and Osman, David and Le Gall, Aëlle and Guitard, Juliette and Joffre, Jérémie and Frapard, Thomas and Coirier, Valentin and Joseph, Adrien and Schmidt, Julien and Argaud, Laurent and Decavèle, Maxens and Lacave, Guillaume and Voirot, Guillaume and Bellal, Mathieu and Neuville, Mathilde and Moreau, Anne-Sophie and Das, Vincent and Agbakou, Maïté and Pichereau, Claire and Quenot, Jean-Pierre and Uhel, Fabrice and Le Pape, Marc and Meireles, Sylvie and Kouatchet, Achille and Contou, Damien and Persichini, Romain and Issa, Nahema and Mokart, Djamel and Lortholary, Olivier and Azoulay, Elie and Lanternier, Fanny and Bigé, Naïke and GRRR-OH (Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologie), GRRR-OH (Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologie)},
title = {Presentation and Prognosis of Cryptococcosis Requiring Intensive Care Unit Admission in France: The CRYPTO-ICU Study},
journal = {Clinical Infectious Diseases},
year = {2026},
doi = {10.1093/cid/ciag091}
}
EUVIMED